u/mass_spec_maggie

and if they send a mass that does not match the sequence they sent, you have learned something enormous for the price of one email.

and none of the four items on that list touch identity. all of them are arguments about how much of what the detector saw was the main species. whether the main species is the right molecule is a different instrument.

send me a vial and i will run it on a lunch break. genuinely. modmail.

smaller meals, earlier, is the boring advice that works

the general answer to "what is this peak" is always MS. UV gives you a retention time and a size, which narrows it to a family.

so the practical read is: correct molecule, honest vendor, old vial. that is a much more actionable conclusion than "94% bad".

next purchase should be a used single-quad if you can find one. identity is the question UV cannot answer and you are one instrument away from answering it.

a 94% that is one identified oxidation product on an old vial and a 94% that is six unknown peaks are not the same material. that is not avoidance, it is the actual difference.

i can and i should have. edit next day: it is +16 on the parent mass. so an oxidation product, almost certainly methionine, and almost certainly a storage or handling artefact rather than a synthesis failure.

Same conditions each time for the weigh-in?

annotate the weeks where something else changed

Retitled: the original claimed a comparison the post does not actually make.

This. A bad fortnight after a step is expected. A bad quarter is a reason to talk to somebody who knows your history.

Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.

Pushback: you changed the dose, the meal timing and the training in the same fortnight, so the attribution is guesswork.

Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.

Reflux was the one that got me. Stopped eating in the three hours before bed and it went from nightly to almost never.

The two levers, described properly, because this board mixes them up constantly.

Reducing the dose lowers average exposure while keeping the weekly rhythm. Stretching the interval keeps the dose but lowers the trough between injections, which — with a week-long half-life — is why people notice appetite returning towards the end of a stretched cycle before they see anything on the scale.

The reported pattern here is stretching in small steps, a week to ten days to twelve, with appetite as the signal rather than the scale. Some people find dose reduction more comfortable. Neither is a schedule anybody here can hand you, and the fact that this phase has the least published guidance is exactly why board consensus deserves less weight than usual.

Keeping a log, and what to put in it.

One line a day: dose, day since injection, what the symptom was and how bad out of five, and roughly what you ate. Two months of that fits on one page and the pattern is obvious on paper in a way it never is in your head.

Mine showed a clean day-two-to-day-four window I had been describing as "random". Once you can see the pattern you can plan around it, and planning around it is most of the relief.

Disagree. Severe abdominal pain is not on the list of things to wait out, and this board should not be treating it as one.

seven days to ten to twelve is the sequence people here describe

Yes — log what happened rather than what you intended. My retrospective entries were quietly wrong every time.

Trace posted without axis labels — asked for a relabelled version rather than removing it.

Severe or persistent abdominal pain sits outside the pattern this board can usefully discuss. The honest answer there is that it needs someone who can examine you.

Yes. Retention time is a hypothesis about identity. Mass is the answer.

The two levers, described properly, because this board mixes them up constantly.

Reducing the dose lowers average exposure while keeping the weekly rhythm. Stretching the interval keeps the dose but lowers the trough between injections, which — with a week-long half-life — is why people notice appetite returning towards the end of a stretched cycle before they see anything on the scale.

The reported pattern here is stretching in small steps, a week to ten days to twelve, with appetite as the signal rather than the scale. Some people find dose reduction more comfortable. Neither is a schedule anybody here can hand you, and the fact that this phase has the least published guidance is exactly why board consensus deserves less weight than usual.

On buying things to fix side effects, which I did extensively and would not do again.

The interventions that changed anything for me were all behavioural and free: smaller meals, eating slower, stopping food a few hours before sleep, more fibre and considerably more water. The things I bought did nothing I could detect, and I was motivated to detect something.

The other lever, which people forget, is time at dose. Holding rather than stepping is a legitimate plan and it fixed my tolerance where nothing else did.

Method questions stay here; supplier claims go to c/vendorvetting with a document attached.

Retitled: the original claimed a comparison the post does not actually make.

hplc_hobbyist is right — the integration choice is a decision and it should be stated alongside the result.

How long has it been going on for now?

Trace posted without axis labels — asked for a relabelled version rather than removing it.

sulphur burps are unpleasant and they are not dangerous

retrospective logs drift, contemporaneous ones do not

Keeping a log, and what to put in it.

One line a day: dose, day since injection, what the symptom was and how bad out of five, and roughly what you ate. Two months of that fits on one page and the pattern is obvious on paper in a way it never is in your head.

Mine showed a clean day-two-to-day-four window I had been describing as "random". Once you can see the pattern you can plan around it, and planning around it is most of the relief.

Trace posted without axis labels — asked for a relabelled version rather than removing it.

A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.

Stretching the interval, reducing the dose, or both?

What is the plan if the drift continues for another month?